Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Parathyroid hormone oral - Unigene

Drug Profile

Parathyroid hormone oral - Unigene

Alternative Names: 768974; GSK 768974; PTH 1-31; PTH 131A; PTH oral - Unigene

Latest Information Update: 12 Jun 2015

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Unigene Laboratories
  • Class Calcium regulators; Osteoporosis therapies; Peptide hormones; Recombinant proteins
  • Mechanism of Action Osteogenesis stimulants; Parathyroid hormone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes - Postmenopausal osteoporosis

Highest Development Phases

  • Discontinued Postmenopausal osteoporosis

Most Recent Events

  • 02 Jul 2013 Discontinued - Phase-II for Postmenopausal osteoporosis in USA (PO)
  • 08 Mar 2012 Parathyroid hormone oral - Unigene is available for licensing (\www.unigene.com\)
  • 06 Dec 2011 Unigene terminates exclusive worldwide license agreement with GlaxoSmithKline and regains all rights to its oral parathyroid hormone product
Restricted Access

If your organization has a subscription then there are several options available to help you access AdisInsight while working remotely. Contact us at AsktheExpert.AdisInsight@springer.com to find out more.
Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top